Top Markets
#1 Fake World Assets Fake World Assets +12.13%
#2 B3 (Base) B3 (Base) +7.21%
#3 OriginTrail OriginTrail +5.67%
#4 BasedHype BasedHype +5.04%
#5 Ontology Ontology +3.60%
#6 Dual Dual +3.59%
#7 Audiera Audiera +3.29%
#8 COTI COTI +3.23%
#9 Strategy PP Variable xStock Strategy PP Variable xStock +3.04%
#10 MVL MVL +2.41%
Coin of the day
Fake World Assets Fake World Assets
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Formosa Pharmaceuticals, Inc. Formosa Pharmaceuticals, Inc.

Formosa Pharmaceuticals, Inc.

6838
Classement en actions #20880
Formosa Pharmaceuticals, Inc., a biopharmaceutical firm situated in Taipei... Formosa Pharmaceuticals, Inc., a biopharmaceutical firm situated in Taipei City, Taiwan, is actively engaged in both late-preclinical and early clinical development stages. Its core focus lies in pioneering therapeutic candidates across ophthalmology, oncology, and anti-infective domains. Among its key investigational assets is APP13007, an ophthalmic nanosuspension, currently progressing through Phase III trials for managing post-surgical discomfort and inflammation of the eye. The company's portfolio also encompasses TSY-0110, designed as an antibody-drug conjugate, and TSY-0210, an antibiotic targeting resilient drug-resistant infections. Further compounds under development include APP13002, a topical antibiotic intended for ocular infections like blepharitis, and MPT0E028, a novel pan-histone deacetylase inhibitor being explored for solid malignancies such as hepatomas and colorectal cancer, in addition to lung fibrosis. Additionally, Formosa Pharmaceuticals maintains a collaborative partnership with Eyenovia, Inc., dedicated to advancing innovative ophthalmic treatments. Established in 2010, the company is headquartered in Taiwan's capital.
Prix de l'action
$0.79338575
Dernière synchronisation: 2026-07-28
Capitalisation boursière
$119.78M
Changement (1 jour)
2.67%
Changement (1 an)
-27.61%
Pays
TW
Échange Formosa Pharmaceuticals, Inc. (6838)

Catégorie

Healthcare
Historique du prix de l'action pour Formosa Pharmaceuticals, Inc. (6838)
Prix de clôture le plus élevé : $0.76 le 2026-07-01

Prix de clôture le plus bas : $1.16 le 2021-10-01
Historique du prix de l'action de Formosa Pharmaceuticals, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 1.64%
2025 -27.82%
2024 -24.76%
2023 -6.74%
2022 43.68%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH